The FASEB Journal, Vol 5, 3023-3030, Copyright © 1991 by The Federation of American Societies for Experimental Biology

REVIEWS

Anatomical distribution and function of dopamine receptors in the kidney

MF Lokhandwala and F Amenta
Department of Pharmacology, University of Houston, TX 77204-5515.

Dopamine receptors of DA-1 and DA-2 subtypes are localized in various regions within the kidney including the renal vasculature (DA-1) as well as sympathetic nerve terminals innervating the renal blood vessels (DA-2). More recent studies using receptor-ligand binding and receptor autoradiography have shown that DA-1 receptors are localized at both the luminal and basolateral membranes at the level of the proximal tubules. Activation of these DA-1 receptors by dopamine and by selective DA-1 receptor agonists results in natriuresis and diuresis. The cellular signaling mechanisms responsible for this response appear to be DA-1 receptor-induced activation of adenylate cyclase and phospholipase C, which via the generation of various intracellular messenger systems cause inhibition of Na(+)-H+ antiport (luminal) and Na+, K(+)-ATPase (basolateral), respectively. Both of these events consequently inhibit sodium reabsorption leading to natriuresis and diuresis. It is also known that dopamine can be synthesized within proximal tubular cells from L-dopa, which is taken up from the tubular lumen, and this locally produced dopamine plays an important role in the regulation of sodium excretion particularly during increases in sodium intake. Furthermore, a defect in the renal dopaminergic mechanism may be one of the pathogenic factors in certain forms of hypertension. Finally, whereas DA-1 receptor agonists are shown to be of therapeutic benefit in the treatment of hypertension, heart failure, and acute renal failure, some selective DA-2 receptor agonists are effective antihypertensive agents.

This article has been cited by other articles:

				D. Jones and R. Bellomo Renal-Dose Dopamine: From Hypothesis to Paradigm to Dogma to Myth and, Finally, Superstition? J Intensive Care Med, July 1, 2005; 20(4): 199 - 211. [Abstract] [PDF]

				D. Bacic, P. Capuano, M. Baum, J. Zhang, G. Stange, J. Biber, B. Kaissling, O. W. Moe, C. A. Wagner, and H. Murer Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells Am J Physiol Renal Physiol, April 1, 2005; 288(4): F740 - F747. [Abstract] [Full Text] [PDF]

				R. Pedrosa, P. Gomes, U. Hopfer, P. A. Jose, and P. Soares-da-Silva Gi{alpha}3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1059 - F1066. [Abstract] [Full Text] [PDF]

				R. Pedrosa, P. A. Jose, and P. Soares-da-Silva Defective D1-like receptor-mediated inhibition of the Cl-/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1120 - F1126. [Abstract] [Full Text] [PDF]

				T. Hussain and M. F. Lokhandwala Renal Dopamine Receptors and Hypertension Experimental Biology and Medicine, February 1, 2003; 228(2): 134 - 142. [Abstract] [Full Text] [PDF]

				A. Ricci, S. Marchal-Victorion, E. Bronzetti, A. Parini, F. Amenta, and S. K. Tayebati Dopamine D4 Receptor Expression in Rat Kidney: Evidence for Pre- and Postjunctional Localization J. Histochem. Cytochem., August 1, 2002; 50(8): 1091 - 1096. [Abstract] [Full Text] [PDF]

				V. A. NARKAR, T. HUSSAIN, C. PEDEMONTE, and M. F. LOKHANDWALA Dopamine D2 Receptor Activation Causes Mitogenesis via p44/42 Mitogen-Activated Protein Kinase in Opossum Kidney Cells J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1844 - 1852. [Abstract] [Full Text] [PDF]

				T. B. Gilbert, J. U. Hasnain, W. R. Flinn, M. P. Lilly, and M. E. Benjamin Fenoldopam Infusion Associated with Preserving Renal Function After Aortic Cross-Clamping for Aneurysm Repair Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 31 - 36. [Abstract] [PDF]

				T. TAKEZAKO, K. NODA, E. TSUJI, M. KOGA, M. SASAGURI, and K. ARAKAWA Adenosine Activates Aromatic L-Amino Acid Decarboxylase Activity in the Kidney and Increases Dopamine J. Am. Soc. Nephrol., January 1, 2001; 12(1): 29 - 36. [Abstract] [Full Text]

				M. A. Vieira-Coelho, T. Hussain, V. Kansra, M. P. Serrao, J. T. Guimaraes, M. Pestana, P. Soares-da-Silva, and M. F. Lokhandwala Aging, High Salt Intake, and Renal Dopaminergic Activity in Fischer 344 Rats Hypertension, October 1, 1999; 34(4): 666 - 672. [Abstract] [Full Text] [PDF]

				T. Hussain, R. Abdul-Wahab, D. K. Kotak, and M. F. Lokhandwala Bromocriptine Regulates Angiotensin II Response on Sodium Pump in Proximal Tubules Hypertension, December 1, 1998; 32(6): 1054 - 1059. [Abstract] [Full Text] [PDF]

				D. Sun, T. W. Wilborn, and J. A. Schafer Dopamine D4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct Am J Physiol Renal Physiol, November 1, 1998; 275(5): F742 - F751. [Abstract] [Full Text] [PDF]

				T. Hussain and M. F. Lokhandwala Renal Dopamine Receptor Function in Hypertension Hypertension, August 1, 1998; 32(2): 187 - 197. [Abstract] [Full Text] [PDF]

				A. Montanari, E. Tateo, E. Fasoli, A. Donatini, B. Cimolato, P. Perinotto, and P. Dall'Aglio Dopamine-2 Receptor Blockade Potentiates the Renal Effects of Nitric Oxide Inhibition in Humans Hypertension, January 1, 1998; 31(1): 277 - 282. [Abstract] [Full Text] [PDF]

				M. C. Hu, L. Fan, L. A. Crowder, Z. Karim-Jimenez, H. Murer, and O. W. Moe Dopamine Acutely Stimulates Na+/H+ Exchanger (NHE3) Endocytosis via Clathrin-coated Vesicles. DEPENDENCE ON PROTEIN KINASE A-MEDIATED NHE3 PHOSPHORYLATION J. Biol. Chem., July 13, 2001; 276(29): 26906 - 26915. [Abstract] [Full Text] [PDF]